328 related articles for article (PubMed ID: 30514793)
1. CD16
Frazao A; Messaoudene M; Nunez N; Dulphy N; Roussin F; Sedlik C; Zitvogel L; Piaggio E; Toubert A; Caignard A
Cancer Immunol Res; 2019 Feb; 7(2):208-218. PubMed ID: 30514793
[TBL] [Abstract][Full Text] [Related]
2. Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.
Messaoudene M; Fregni G; Fourmentraux-Neves E; Chanal J; Maubec E; Mazouz-Dorval S; Couturaud B; Girod A; Sastre-Garau X; Albert S; Guédon C; Deschamps L; Mitilian D; Cremer I; Jacquelot N; Rusakiewicz S; Zitvogel L; Avril MF; Caignard A
Cancer Res; 2014 Jan; 74(1):81-92. PubMed ID: 24225017
[TBL] [Abstract][Full Text] [Related]
3. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer.
Rezaeifard S; Talei A; Shariat M; Erfani N
Mol Immunol; 2021 Aug; 136():161-167. PubMed ID: 34171565
[TBL] [Abstract][Full Text] [Related]
4. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
[TBL] [Abstract][Full Text] [Related]
5. The early expansion of anergic NKG2A
Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
[TBL] [Abstract][Full Text] [Related]
6. Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes.
Rethacker L; Boy M; Bisio V; Roussin F; Denizeau J; Vincent-Salomon A; Borcoman E; Sedlik C; Piaggio E; Toubert A; Dulphy N; Caignard A
Oncoimmunology; 2022; 11(1):2057396. PubMed ID: 35371620
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
8. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
[TBL] [Abstract][Full Text] [Related]
9. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
11. Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1.
Ziblat A; Iraolagoitia XLR; Nuñez SY; Torres NI; Secchiari F; Sierra JM; Spallanzani RG; Rovegno A; Secin FP; Fuertes MB; Domaica CI; Zwirner NW
Front Immunol; 2021; 12():681615. PubMed ID: 34149719
[TBL] [Abstract][Full Text] [Related]
12. Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.
Hromadnikova I; Pirkova P; Sedlackova L
Mediators Inflamm; 2013; 2013():405295. PubMed ID: 23476104
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory receptor CD94/NKG2A on CD8
Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
[TBL] [Abstract][Full Text] [Related]
15. HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.
Lauterbach N; Wieten L; Popeijus HE; Voorter CE; Tilanus MG
Hum Immunol; 2015 Aug; 76(8):578-86. PubMed ID: 26382247
[TBL] [Abstract][Full Text] [Related]
16. Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
Yoshioka T; Tatsumi T; Miyagi T; Mukai K; Nishio K; Nishio A; Yokoyama Y; Suda T; Kegasawa T; Shigekawa M; Hikita H; Sakamori R; Takehara T
PLoS One; 2017; 12(3):e0174103. PubMed ID: 28328926
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
Comeau EM; Holder KA; Fudge NJ; Grant MD
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
[TBL] [Abstract][Full Text] [Related]
18. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
Sáez-Borderías A; Romo N; Magri G; Gumá M; Angulo A; López-Botet M
J Immunol; 2009 Jan; 182(2):829-36. PubMed ID: 19124726
[TBL] [Abstract][Full Text] [Related]
19. CD56
Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
